for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover Consumer Drugs
  [0 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1206
   Published by Informa plc Homepage  [9 journals]
  • Nurofen Ad 'Headache' Audio Without Visual Makes General
           Pain Claim
    • Abstract: UK advertising regulator says a voice-over in an ad "specifically referenced headache relief" but also stated Nurofen OTC product “acts...      Related Stories
      Medicines In The Environment: EU Moots Action On ‘Green’ Manufacturing, Pack Sizes, Discharges
      Pharma Faces More Probes On Generic Price Hikes in UK
      Global Pharma Guidance Tracker – October 2017 
      PubDate: Wed, 22 Nov 2017 18:46:11 GMT
       
  • Consumer Health Weekly Trademark Review Nov. 15, 2017
    • Abstract: Compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 (Cosmetics and Cleaning Preps) and Class...      Related Stories
      Medicines In The Environment: EU Moots Action On ‘Green’ Manufacturing, Pack Sizes, Discharges
      Pharma Faces More Probes On Generic Price Hikes in UK
      Global Pharma Guidance Tracker – October 2017 
      PubDate: Tue, 21 Nov 2017 12:59:43 GMT
       
  • Clearblue Connects Peak Fertility Data To Smartphone App
    • Abstract: P&G?s connected Clearblue tracks a user’s personal hormone profile and sends data to a smartphone, typically alerting on the four...      Related Stories
      French Regulator Wants More Trial Sponsors To Take Part In Pilot Of Future EU Procedures
      EFPIA Welcomes EMA’s Electronic Format Plan For Package Leaflets But Not ‘Key Info’ Idea
      Keeping Track: A Second Straight Burst Of FDA Approvals 
      PubDate: Fri, 17 Nov 2017 15:43:17 GMT
       
  • Pricing Pressures 'Manageable' To P&G, But
           Threatening To Analysts
    • Abstract: Procter & Gamble says retailer pressure for the firm to lower product pricing to compete with e-commerce and private label...      Related Stories
      French Regulator Wants More Trial Sponsors To Take Part In Pilot Of Future EU Procedures
      EFPIA Welcomes EMA’s Electronic Format Plan For Package Leaflets But Not ‘Key Info’ Idea
      Clearblue Connects Peak Fertility Data To Smartphone App 
      PubDate: Fri, 17 Nov 2017 15:43:17 GMT
       
  • P&G Board Seat Swings To Peltz In Ongoing Vote Tally
    • Abstract: P&G says results from an independent tabulator indicate Trian Fund head Nelson Peltz is leading the firm?s candidate, Ernesto Zedillo...      Related Stories
      French Regulator Wants More Trial Sponsors To Take Part In Pilot Of Future EU Procedures
      Recent And Upcoming FDA Advisory Committee Meetings
      Bayer?s Inhaled Cipro Cannot Surmount Inconsistent Efficacy Data At US FDA Panel 
      PubDate: Wed, 15 Nov 2017 19:13:47 GMT
       
  • Change At Bayer Consumer Helm As Drive To Top Stalls
    • Abstract: Bayer hires Heiko Schipper away from Nestle?s nutritional products business to succeed Erica Mann as its consumer division chief. Mann...      Related Stories
      French Regulator Wants More Trial Sponsors To Take Part In Pilot Of Future EU Procedures
      Recent And Upcoming FDA Advisory Committee Meetings
      Bayer?s Inhaled Cipro Cannot Surmount Inconsistent Efficacy Data At US FDA Panel 
      PubDate: Wed, 15 Nov 2017 17:12:34 GMT
       
  • Consumer Health Weekly Trademark Review Nov. 7, 2017
    • Abstract: Compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 (Cosmetics and Cleaning Preps) and Class...      Related Stories
      French Regulator Wants More Trial Sponsors To Take Part In Pilot Of Future EU Procedures
      Recent And Upcoming FDA Advisory Committee Meetings
      Bayer?s Inhaled Cipro Cannot Surmount Inconsistent Efficacy Data At US FDA Panel 
      PubDate: Wed, 15 Nov 2017 10:47:55 GMT
       
  • Promotional Lip Balm, Sanitizer Imports Blocked On Drug GMP Problems
    • Abstract: In addition to AZX Sport lip balms and hand sanitizers, other topical consumer drugs often considered personal care or cosmetic...      Related Stories
      European CHMP Opinions And MAA Updates
      Why Industry Wants ICH To Harmonize Process Validation Guidance
      French Govt Calls For 70% Biosimilar Prescribing Rate; Substitution Groups Published 
      PubDate: Mon, 13 Nov 2017 16:49:48 GMT
       
  • Private Label Nexium OTC Buoys Perrigo As Pricing Trims Rx Revenues
    • Abstract: Perrigo?s third-quarter launch of private label Nexium24HR was primary contributor of $13m in new product sales in North America.      Related Stories
      European CHMP Opinions And MAA Updates
      Why Industry Wants ICH To Harmonize Process Validation Guidance
      French Govt Calls For 70% Biosimilar Prescribing Rate; Substitution Groups Published 
      PubDate: Fri, 10 Nov 2017 16:04:43 GMT
       
  • Merck, Pfizer Decorate Consumer Health 'For Sale' Signs
           With Strong Results
    • Abstract: Merck KGAA reports 11% growth in sales of its OTC lines over a year ago, but, like Pfizer, looks to...      Related Stories
      Recent And Upcoming FDA Advisory Committee Meetings
      Merck, Pfizer Decorate Consumer Health ?For Sale? Signs With Strong Results
      ‘Not Enough Time’ To Transfer All Marketing Authorizations In Case Of ‘No-Deal’ Brexit, says EFPIA 
      PubDate: Thu, 09 Nov 2017 18:10:44 GMT
       
  • Potential Buyers Assess Available OTC Assets From Disparate Views
    • Abstract: As Merck KGAA and Pfizer shop their consumer health businesses, large pharmas J&J, Bayer AG and Sanofi, health and household...      Related Stories
      Recent And Upcoming FDA Advisory Committee Meetings
      Merck, Pfizer Decorate Consumer Health ?For Sale? Signs With Strong Results
      ‘Not Enough Time’ To Transfer All Marketing Authorizations In Case Of ‘No-Deal’ Brexit, says EFPIA 
      PubDate: Thu, 09 Nov 2017 17:22:19 GMT
       
  • Consumer Health Weekly Trademark Review Oct. 31, 2017
    • Abstract: Compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 (Cosmetics and Cleaning Preps) and Class...      Related Stories
      A Race Against Time: EMA Wants “Immediate” Action On Brexit Relocation Challenges
      EU CHMP To Review July Rejection Of Drugs For Schizophrenia, Metastatic Breast Cancer
      Shareholders Challenge Perrigo?s Defense Against Mylan Offer Two Years Earlier 
      PubDate: Tue, 07 Nov 2017 16:35:37 GMT
       
  • Shareholders Challenge Perrigo's Defense Against Mylan Offer Two
           Years Earlier
    • Abstract: Perrigo concealed problems related to its 2015 acquisition of Omega and over-inflated the firm’s resistance to generic drug pricing pressures...      Related Stories
      A Race Against Time: EMA Wants “Immediate” Action On Brexit Relocation Challenges
      EU CHMP To Review July Rejection Of Drugs For Schizophrenia, Metastatic Breast Cancer
      Novartis Seeks EU Accelerated Review For CAR-T Therapy 
      PubDate: Tue, 07 Nov 2017 16:08:42 GMT
       
  • FDA Adds 'Doctor' To CV Statement For OTC Aspirin Labeled
           With Hearts
    • Abstract: In response to the US agency?s guidance announced Nov. 6, the pharmaceutical firm whose name is synonymous with the ingredient...      Related Stories
      A Race Against Time: EMA Wants “Immediate” Action On Brexit Relocation Challenges
      EU CHMP To Review July Rejection Of Drugs For Schizophrenia, Metastatic Breast Cancer
      Shareholders Challenge Perrigo?s Defense Against Mylan Offer Two Years Earlier 
      PubDate: Mon, 06 Nov 2017 18:56:36 GMT
       
  • Consumer Health Weekly Trademark Review Oct. 24, 2017
    • Abstract: Compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 (Cosmetics and Cleaning Preps) and Class...      Related Stories
      Four Biosimilar Pegfilgrastims Under EU Review After Sandoz Re-Submits Zioxtenzo
      US Pharma Firms Warn ‘Hard’ Brexit Will Impact UK Investments; Clinical Trials A Casualty Of Uncertainty
      Indivior?s Monthly Injectable Buprenorphine Wins Panel Backing; US FDA May Limit Dosage 
      PubDate: Wed, 01 Nov 2017 10:15:00 GMT
       
  • Trade Panel Bolsters FDA's View In Amarin Omega-3 Complaint
    • Abstract: International Trade Commission won?t investigate Amarin?s complaint that some dietary supplements containing omega-3 formulations similar to icosapent ethyl in its...      Related Stories
      Four Biosimilar Pegfilgrastims Under EU Review After Sandoz Re-Submits Zioxtenzo
      Consumer Health Weekly Trademark Review Oct. 24, 2017
      US Pharma Firms Warn ‘Hard’ Brexit Will Impact UK Investments; Clinical Trials A Casualty Of Uncertainty 
      PubDate: Mon, 30 Oct 2017 17:53:22 GMT
       
  • Making OTC Topical Drugs In Kitchen Stirs Up Problems For Oregon Firm
    • Abstract: FDA expects Pain Relief Naturally to recall lidocaine-containing hemorrhoid, bed sore and pre-tattoo lotions and sprays. In addition to GMP...      Related Stories
      Brexit Already Affecting UK Regulator’s Role In Marketing Authorizations
      USP Mulls Rapid Sterility Testing Standards For Cell Therapies, PET Drugs And Sterile Compounding
      Keeping Track: A Burst of CRLs and BTDs, A Busy Week Of Submissions And Another Approval For Soliris 
      PubDate: Thu, 26 Oct 2017 17:34:35 GMT
       
  • Reckitt Negotiating Details For Generic Mucinex It Will Provide Mutual
    • Abstract: Litigation over supply agreement stayed after firms indicated to US district court they would settle. Mutual showed that RB failed...      Related Stories
      Australia To Bring Complex Stem Cell Therapies Within Regulatory Fold
      How To Find And Remedy Data Integrity Lapses In Microbiology Labs
      EMA’s Clinical Data Policy One Year On: 50 Products, 3,000 Documents And ‘Positive Feedback’ 
      PubDate: Wed, 25 Oct 2017 16:06:18 GMT
       
  • Decision Against Attorney Fees In Mucinex Patent Claim Could Resonate
    • Abstract: US federal court judge says Mucinex marketer Reckitt Benckiser is not responsible for OTC private label competitor Aurobindo’s attorney fees...      Related Stories
      Australia To Bring Complex Stem Cell Therapies Within Regulatory Fold
      How To Find And Remedy Data Integrity Lapses In Microbiology Labs
      EMA’s Clinical Data Policy One Year On: 50 Products, 3,000 Documents And ‘Positive Feedback’ 
      PubDate: Wed, 25 Oct 2017 15:17:29 GMT
       
  • Reckitt Benckiser Gives Consumer Health Portfolio Its Own Home –
           What's Next'
    • Abstract: UK manufacturer in January begins operating with a separate health care division, representing 60% of sales with products including Mucinex...      Related Stories
      ICH Expansion To Bring New Challenges For Global Consensus On Pediatric Extrapolation
      Industry Welcomes EU Action Plan To Boost ATMP Development
      Consumer Health Weekly Trademark Review Oct. 17, 2017 
      PubDate: Mon, 23 Oct 2017 18:15:03 GMT
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 23.20.162.200
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2016